LRN Q1 2026 Earnings EPS Beat Drives Positive Momentum Despite Revenue Uncertainty EXAS Q4 2025 Earnings Significant EPS Miss Amidst Challenging Quarter RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32 Xenetic Biosciences Q2 2025 Earnings Narrowed Loss Exceeds Expectations Amid Oncology Pipeline Progress Hennessy Advisors Q1 2026 Earnings EPS of 024 Reported Bond Price Edges Lower Oyster Enterprises II Acquisition Corp Rights OYSER Holds Steady at 014 Amid LowVolume Consolidation Syntec Optics OPTX Surges 693 as Optics Stock Tests Key Resistance Farmers Merchants Bancorp FMAO Slips 1 Support and Resistance Levels in Focus BlackRock Credit Allocation Income Trust BTZ Edges Higher as Income Investors Test Resistance Core Scientific CORZ Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction